Pelorus Equity Group

TerrAscend Corp. is a Canadian cannabis company that cultivates, processes, and sells both medical and adult-use cannabis in Canada, the United States, and Europe. Founded in 2017 and headquartered in Mississauga, the company emphasizes a vertically-integrated approach, ensuring quality in its product offerings. TerrAscend operates retail dispensaries in California and Pennsylvania, and it also produces hemp-derived wellness products and cannabis-infused artisan edibles. The company offers support and education programs for patients and physicians through its subsidiaries, Solace Health Inc. and Terra Health Network Inc., which provide clinical support and consultations for medical cannabis. Additionally, TerrAscend focuses on drug research and development, as well as innovative cannabis delivery systems, to meet the diverse needs of its patient base.

TransCanna is a logistics and supply chain company that specializes in providing branding, transportation, and distribution services. It specializes in freight forwarding and its services cover the fields of the cannabis industry and marketplace. The company was founded in 2017 and is headquartered in Vancouver, British Columbia.

Juva Life Inc. is a cannabis company headquartered in Vancouver, Canada, that specializes in the cultivation, research, manufacturing, distribution, and sale of pharmacy-grade medical and recreational cannabis products in California. Founded in 2018, Juva Life employs a vertically integrated approach, enabling the company to manage all aspects of development, from cultivation to consumer distribution. This strategy allows for rigorous oversight and ensures the quality and consistency of its products. The company operates through two main segments: the resale of cannabis-derived merchandise and the cultivation and sale of cannabis trim and flowers. Juva Life combines its extensive knowledge of the science and medicinal effects of cannabis with thorough research and testing practices to guarantee the accuracy and legitimacy of its product offerings.

Royal Emerald Pharmaceuticals is dedicated to producing non-addictive alternative medicines aimed at addressing post-traumatic stress disorder (PTSD) and various health issues, with a particular focus on supporting veterans. The company operates under the guidance of experienced professionals from the corporate and medical sectors, ensuring high standards in its offerings. Royal Emerald provides a comprehensive range of services that include bulk drug supply, clinical trial support, and cGMP manufacturing, all designed to meet the evolving needs of researchers, government agencies, and industry partners. By prioritizing the development of non-addictive medications, the company aspires to lead the pharmaceutical sector in creating safer therapeutic options for consumers.

Harborside is a California-focused, vertically-integrated cannabis enterprise.